Social Pulse: Pfizer Inc (PFE)
PFE on New York Consolidated
8 Oct 2015
8 Oct 2015
Change (% chg)
- Dividend Ideas: Superior Returns From Shrinking Shares
- Top 2 Trade Alert Ideas October 8: Achaogen's Risk/Reward Profile, ContraVir Rally, Earnings Season
- Premarket Biotech Digest: Evoke Pharma Rallies, Avelumab Fast Tracked, Vertex's Milestone
- Did Express Scripts Just Give A 'Buy' Recommendation On Amgen And Regeneron?
- Higher Interest Rates Lead To Increased Volatility - How To Prepare For A Volatile Market
- Is S&P 500 Market Leadership Changing?
- Pfizer Invites Public To View And Listen To Webcast Of January 29 Conference Call With Analysts
- Pfizer Declares First-Quarter 2013 Dividend
- U.S. Food and Drug Administration (FDA) Accepts New Drug Application For Bazedoxifene/Conjugated Estrogens, An Investigational Treatment For Symptoms Associated With Menopause And Prevention of Osteoporosis
- U.S. Food And Drug Administration (FDA) Accepts New Drug Application For Bazedoxifene/Conjugated Estrogens, An Investigational Treatment For Symptoms Associated With Menopause And Prevention Of Osteoporosis
- ELIQUIS® (apixaban) Demonstrated Superiority In Reducing A Composite Of Recurrent Venous Thromboembolism And All-Cause Death Without Increasing The Rate Of Major Bleeding Versus Placebo During One Year Of Extended Treatment